ClinicalTrials.Veeva

Menu

Increasing Use of Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes

Stanford University logo

Stanford University

Status

Terminated

Conditions

Type1diabetes

Treatments

Behavioral: gamification
Behavioral: Use of Dexcom G5

Study type

Interventional

Funder types

Other

Identifiers

NCT03297762
IRB-36423

Details and patient eligibility

About

To use an enhanced continuous glucose monitor (CGM) experience, including an automated CGM-electronic health record (EHR) data integration system, proactive interventions, and gamification techniques, to increase CGM use among publicly-insured youth with type 1 diabetes (T1D).

Full description

The investigators will use an automated data integration system to monitor hours per week the CGM is worn and target interventions/troubleshooting techniques as needed. The investigators will use gamification techniques (i.e. ability to gain points and achieve small rewards) to help encourage CGM use and potentially improve glycemic control in this at-risk population.

Enrollment

4 patients

Sex

All

Ages

13 to 19 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • type 1 diabetes for more than 6 months
  • on insulin pump or multiple daily injections without plans to change modality in next 6 months
  • insured by CCS or Medi-Cal
  • receiving care at Lucile Packard Children's Hospital or Stanford Children's Health outpatient clinics
  • English or Spanish-speaking

Exclusion criteria

  • major illness or condition that may alter glucose control or ability to complete the study including pregnancy, cystic fibrosis, cancer, liver disease, history of transplant, or hemoglobinopathy
  • current oral glucocorticoid use
  • prior use of a CGM system
  • hemoglobin A1C <7.5% or >12%
  • no wireless internet access

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

4 participants in 2 patient groups

Gamification
Experimental group
Description:
Use of continuous glucose monitor (Dexcom G5) with proactive intervention and incentives for time in use.
Treatment:
Behavioral: Use of Dexcom G5
Behavioral: gamification
Standard care
Active Comparator group
Description:
Use of continuous glucose monitor (Dexcom G5) per usual care.
Treatment:
Behavioral: Use of Dexcom G5

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems